Apple, Inc.: FDA filings under this applicant name
FDA lists 9 510(k) clearances under the applicant name “Apple, Inc.” (first 2020, latest 2026), plus 3 De Novo decisions, across 7 product codes in 5 review panels. Median 510(k) review time under this name: 135 days. Since 2017 the median was 135 days, against 146 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2020 | 1 | 122 |
| 2021 | 1 | 73 |
| 2022 | 1 | 165 |
| 2023 | 1 | 87 |
| 2024 | 2 | 130 |
| 2025 | 2 | 180 |
| 2026 | 1 | 135 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Apple, Inc. took a median 135 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 146 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| QDB | Photoplethysmograph Analysis Software For Over-The-Counter Use | 4 | 3 |
| QDA | Electrocardiograph Software For Over-The-Counter Use | 2 | 1 |
| SCW | Digital Prismatic Correction | 2 | 2 |
| QZW | Over-The-Counter Device To Assess Risk Of Sleep Apnea | 1 | 1 |
| SCR | Air-Conduction Hearing Aid Software | 1 | 0 |
| SFR | Hypertension Machine Learning-Based Notification Software | 1 | 1 |
| SHN | Calibration Software For Radiology Displays | 1 | 1 |
Review panels
- Cardiovascular (7)
- Ophthalmic (2)
- Anesthesiology (1)
- Ear, Nose and Throat (1)
- Radiology (1)
Most recent Apple, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K253582 | Medical Imaging Calibration Feature (MICF) | SHN | 2026-04-01 | 135 |
| K250507 | Hypertension Notification Feature (HTNF) | SFR | 2025-09-11 | 202 |
| K250143 | Digital Prism Correction Feature (DPCF) | SCW | 2025-06-23 | 157 |
| K242058 | Digital Prism Correction Feature (DPCF) | SCW | 2024-10-21 | 98 |
| K240929 | Sleep Apnea Notification Feature (SANF) | QZW | 2024-09-13 | 162 |
| K231173 | Irregular Rhythm Notification Feature (IRNF) | QDB | 2023-07-21 | 87 |
| K213971 | Atrial Fibrillation History Feature | QDB | 2022-06-03 | 165 |
| K212516 | IRNF App | QDB | 2021-10-22 | 73 |
| K201525 | ECG App | QDA | 2020-10-08 | 122 |
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN230081 | De Novo | Air-Conduction Hearing Aid Software | 2024-09-12 |
| DEN180044 | De Novo | Electrocardiograph Software For Over-The-Counter Use | 2018-09-11 |
| DEN180042 | De Novo | Photoplethysmograph Analysis Software For Over-The-Counter Use | 2018-09-11 |
Recalls
FDA recall records list no recalls under a recalling firm named Apple, Inc..
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Apple, Inc. is the lead sponsor of 6 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:
- NCT05872035: Smartphone Enabled Hearing Study (Completed, started 2023-04-20)
- NCT04699812: Atrial Fibrillation Algorithms Clinical Validation Study (Completed, started 2020-11-16)
- NCT04247581: ECG App Algorithms Clinical Validation Study (Completed, started 2020-01-07)
- NCT03769207: Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias (Completed, started 2018-12-08)
- NCT03492554: Electrocardiogram Clinical Validation Study (Completed, started 2018-03-12)
SEC filings
Apple Inc. (AAPL): EDGAR filings, CIK 320193. An SEC registrant with the same name, matched by name only.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Apple Medical Corp. (9 510(k)s)
- Apple Diagnostic Products (7 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Apple, Inc.?
FDA lists 9 510(k) clearances under the applicant name “Apple, Inc.” (first 2020, latest 2026), plus 3 De Novo decisions, across 7 product codes in 5 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Apple, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Apple, Inc. is 135 days. Since 2017: 135 days, versus 146 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Apple, Inc.?
The most frequent FDA product codes under this applicant name are QDB (Photoplethysmograph Analysis Software For Over-The-Counter Use, 4); QDA (Electrocardiograph Software For Over-The-Counter Use, 2); SCW (Digital Prismatic Correction, 2).
Next steps
- See all 9 Apple, Inc. clearances with predicates and recalls
- Run predicate analysis for product code QDB, Apple, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.